Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. More Details
Mediocre balance sheet and overvalued.
Share Price & News
How has Harvest One Cannabis's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HVT is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 18% a week.
Volatility Over Time: HVT's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
7 Day Return
1 Year Return
Return vs Industry: HVT underperformed the Canadian Pharmaceuticals industry which returned 14.8% over the past year.
Return vs Market: HVT underperformed the Canadian Market which returned -0.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Harvest One Cannabis's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 months ago | Simply Wall StHow Does Harvest One Cannabis Inc. (CVE:HVT) Affect Your Portfolio Volatility?
10 months ago | Simply Wall StThe Harvest One Cannabis (CVE:HVT) Share Price Is Down 81% So Some Shareholders Are Rather Upset
1 year ago | Simply Wall StWill Harvest One Cannabis (CVE:HVT) Spend Its Cash Wisely?
Is Harvest One Cannabis undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate HVT's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate HVT's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: HVT is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.
PE vs Market: HVT is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate HVT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: HVT is good value based on its PB Ratio (0.4x) compared to the CA Pharmaceuticals industry average (1.5x).
How is Harvest One Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Harvest One Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of HVT’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Harvest One Cannabis competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has Harvest One Cannabis performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HVT is currently unprofitable.
Growing Profit Margin: HVT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: HVT is unprofitable, and losses have increased over the past 5 years at a rate of 66% per year.
Accelerating Growth: Unable to compare HVT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HVT is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-45%).
Return on Equity
High ROE: HVT has a negative Return on Equity (-171.65%), as it is currently unprofitable.
How is Harvest One Cannabis's financial position?
Financial Position Analysis
Short Term Liabilities: HVT's short term assets (CA$28.4M) exceed its short term liabilities (CA$19.2M).
Long Term Liabilities: HVT's short term assets (CA$28.4M) exceed its long term liabilities (CA$2.1M).
Debt to Equity History and Analysis
Debt Level: HVT's debt to equity ratio (14.7%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if HVT's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HVT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: HVT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 50% each year
What is Harvest One Cannabis's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate HVT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HVT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HVT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HVT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of HVT's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Gord Davey has been President, Interim Chief Executive Officer and Director at Harvest One Cannabis Inc. since October 9, 2020. Mr. Davey was the Senior Vice President of Global Sales at Harvest One Ca...
|Executive Chairman||1.92yrs||CA$26.38k||no data|
|no data||CA$331.48k||no data|
|President||0.083yr||no data||no data|
|Interim Chief Financial Officer||0.33yr||no data||no data|
|Chief technology Officer||3.5yrs||CA$171.02k||no data|
|Vice President of Investor Relations||no data||no data||no data|
|Senior Vice President of Corporate Communications||2.17yrs||no data||no data|
|Senior Vice President of Corporate & Public Affairs||2.08yrs||CA$30.00k||no data|
|Corporate Secretary||2.08yrs||no data||no data|
|Vice President of Finance||3.42yrs||CA$95.37k||no data|
Experienced Management: HVT's management team is considered experienced (2.1 years average tenure).
|Executive Chairman||1.92yrs||CA$26.38k||no data|
|President||0.083yr||no data||no data|
|Independent Director||3.58yrs||CA$36.00k||no data|
|Member of the Advisory Board||2.17yrs||no data||no data|
|Director||0.67yr||no data||no data|
Experienced Board: HVT's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Harvest One Cannabis Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Harvest One Cannabis Inc.
- Ticker: HVT
- Exchange: TSXV
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$12.905m
- Shares outstanding: 215.08m
- Website: https://www.harvestone.com
Number of Employees
- Harvest One Cannabis Inc.
- 885 West Georgia Street
- Suite 1400
- British Columbia
- V6C 3E8
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|HVT||TSXV (TSX Venture Exchange)||Yes||Common Shares||CA||CAD||Apr 2017|
|HRVO.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Apr 2017|
|2CN||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Apr 2017|
Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medica...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/27 23:18|
|End of Day Share Price||2020/11/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.